11th Annual PTCTC Educational Meeting at ASPHO - In-person
The Pediatric Transplantation and Cellular Therapy Consortium in collaboration with ASPHO will present its 11th annual full day conference focused on Pediatric BMT and cellular therapies. The theme of this conference is “First 100 Days”. Clinicians and scientists will present the ‘state-of-the-science’ on the most troubling complications for patients, families, and providers in the early days after transplant. Abstracts of new research findings will be presented. An exciting evening of mentoring and networking will follow at our "Meet the Professors".
Tuesday, April 02, 2024
Seattle, WA - Seattle Convention Center: Room 4C-1 and 4C-2.
6:30am-5:15pm PT - Main meeting - Room 4C-1 and 4C-2
5:15-6:30pm PT - Poster Session - Room 4C-3
6:30-8:30pm PT - Evening Event/Mentoring and Networking, "Meet the Professors" Location TBD
View Draft agenda here
If you are interested in attending the Joint ASPHO / PTCTC Conferences, please click here.
*Lactation rooms available at the Convention Center. Please see meeting contact onsite.
Any questions, please reach out to PTCTC@nmdp.org
Continuing Medical Education Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Pediatric Hematology/Oncology (ASPHO) and the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC).
The American Society of Pediatric Hematology/Oncology is accredited by the ACCME to provide continuing medical education for physicians.
The American Society of Pediatric Hematology/Oncology designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, ASPHO requires all planners, faculty (presenters and moderators), reviewers, teachers, authors, and any others involved in the development of CME content to disclose all financial relationships they have with ineligible companies in the last 24 months. Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ASPHO also requires disclosure of the intent to discuss unlabeled or investigational use(s) of a commercial product or investigational use of a product not yet approved for this purpose. The ASPHO Accreditation Subcommittee reviews all financial relationships as submitted in the disclosure form by planners and presenters and mitigates such conflicts to ensure the content of the activity is aligned with the interests of the public.
The material presented in this activity represents the opinion of the speakers and not necessarily the views of ASPHO.